Where Precision
                                    
                                    Meets Convenience
                                
                                : Inspiring Point of Care Molecular Diagnostics
Precise and Convenient Solution 
for On-site Molecular Diagnostics.
                            Instrument
Consumables
- 
                                    Human PathogensHuman PathogensRapid and Precise PCR Test Using Its Unique Biochip Technology. 
- 
                                    Veterinary DiagnosticsVeterinary DiagnosticsRapid and Precise PCR Test Suitable for Fast Growing Veterinary Healthcare Market Pet Disease Diagnostics- Canine - Skin Disease Panel
- Canine - Tick-borne Disease Panel
- Canine - Gastroenteritis Disease Panel Ⅰ
- Canine - Gastroenteritis Disease Panel Ⅱ
- Canine - Respiratory Disease Panel Ⅰ
- Canine - Respiratory Disease Panel Ⅱ
- Canine - Neurological Disease Panel
- Feline - Upper Respiratory Tract Disease
- Feline - Respiratory Disease Panel Ⅰ
- Feline - Respiratory Disease Panel Ⅱ
- Feline - Neurological Disease Panel Ⅰ
- Feline - Neurological Disease Panel Ⅱ
 
- 
                                    Food SafetyFood SafetyRapid and Precise PCR Test to Lead The Fast-changing Food Safety Market 
                                Genesystem is a biotech engineering company specializing
                                in molecular diagnostic solutions to target point-of-care testing applications.
                            
- 
                                    Hardware Technology
- 
                                    High Multiplex
- 
                                    Biochip Technology
- 
                                    Phase I2010~2016Commercialization of 
 Rapid Molecular Testing Platform- Ultra-fast PCR Technology
- Miniaturized Heating Module Technology
- PCR Reagents Optimized for Ultra-fast PCR
 
- 
                                    Phase II2017~2019R&D of Biochip Based Multiplex and Sample Prep Technology - Multiplex Biochip Technology
- Rapid Sample Preparation Technology
 
- 
                                    Phase III2020~2024R&D and Commercialization of Multiplex POCT Solutions - High Multiplex Technology
- One-step Rapid Molecular Testing Platform Technology
 
- 
                                    Phase IV2025~Diversification of Multiplex POCT Business - R&D and Procurement of Biomarkers
- One-step Rapid Molecular Testing Platform Technology
 
 
                                         
                                         
                                        